Smartleaf Asset Management LLC Tg Therapeutics, Inc. Transaction History
Smartleaf Asset Management LLC
- $610 Billion
- Q2 2024
A detailed history of Smartleaf Asset Management LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 248 shares of TGTX stock, worth $5,322. This represents 0.0% of its overall portfolio holdings.
Number of Shares
248
Previous 33
651.52%
Holding current value
$5,322
Previous $581,000
666.09%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TGTX
# of Institutions
287Shares Held
91.8MCall Options Held
1.9MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA13.7MShares$294 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$244 Million0.0% of portfolio
-
State Street Corp Boston, MA6.7MShares$144 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.65MShares$78.2 Million6.57% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.24MShares$69.6 Million0.07% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $3.12B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...